Cargando…
The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson’s Disease: A Systematic Literature Review of Pre-Clinical Studies
Currently, there are no pharmacological treatments able to reverse nigral degeneration in Parkinson’s disease (PD), hence the unmet need for the provision of neuroprotective agents. Cannabis-derived phytocannabinoids (CDCs) and resveratrol (RSV) may be useful neuroprotective agents for PD due to the...
Autores principales: | Prakash, Samay, Carter, Wayne G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699487/ https://www.ncbi.nlm.nih.gov/pubmed/34942876 http://dx.doi.org/10.3390/brainsci11121573 |
Ejemplares similares
-
A systematic review of minor phytocannabinoids with promising neuroprotective potential
por: Stone, Nicole L., et al.
Publicado: (2020) -
Analytical Techniques for Phytocannabinoid Profiling of Cannabis and Cannabis-Based Products—A Comprehensive Review
por: Stefkov, Gjoshe, et al.
Publicado: (2022) -
Metabolomic analysis of methyl jasmonate treatment on phytocannabinoid production in Cannabis sativa
por: Welling, Matthew T., et al.
Publicado: (2023) -
Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice
por: Paes-Colli, Yolanda, et al.
Publicado: (2022) -
Phytocannabinoids Profile in Medicinal Cannabis Oils: The Impact of Plant Varieties and Preparation Methods
por: Dei Cas, Michele, et al.
Publicado: (2020)